Navigation Links
ULURU Inc. Announces Conference Call To Discuss Financial Results For The Second Quarter Ended June 30, 2014 And To Provide A Business Update
Date:8/7/2014

ADDISON, Texas, Aug. 7, 2014 /PRNewswire/ -- ULURU Inc. (OTCQB: ULUR) today announced that it has scheduled a conference call to discuss the second quarter ending June 30, 2014 financial results and to provide a business update on August, 15, 2014 at 9:00 a.m. Eastern Time.

To participate in the conference call please dial (877) 387-2201, for international callers dial (850) 429-1388 (access code 24097#) five to ten minutes prior to the initiation of the teleconference.  If you are unable to listen to the live broadcast, a replay of the call will be available starting on August 15, 2014 two hours following the end of the call until August 29, 2014 at 11:59 p.m. Eastern Time.  For the U.S. replay, please dial (866) 415-9493 and international callers please dial (205) 289-3247 (access code 24097#).  You may also access the replay of the call two hours following the end of the call until August 29, 2014 at 11:59 p.m. Eastern Time via the web by logging onto http://replay.multipointcom.com.

About ULURU Inc.:ULURU Inc. is a specialty pharmaceutical company focused on the development of a portfolio of wound management and oral care products to provide patients and consumers with improved clinical outcomes through controlled delivery utilizing its innovative Nanoflex® Aggregate technology and OraDisc™ transmucosal delivery system. For more information about ULURU Inc., please visit www.uluruinc.com.  For more information about Altrazeal®, please visit www.Altrazeal.com.

This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended. These statements are subject to numerous risks and uncertainties, including but not limited to the risk factors detailed in the Company's Annual Report on Form 10-K for the year ended December 31, 2013 and other reports filed by us with the Securities and Exchange Commission.Contact: Investor RelationsContact: CompanyJim MacDonald Kerry P. Gray Torrey Hills CapitalPresident & CEO (858) 456-7300 Terry K. Wallberg Vice President & CFO(214) 905-5145 

 

 


'/>"/>
SOURCE ULURU Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. ULURU Inc. Announces the Expansion of the International Marketing Network
2. ULURU Inc. Reports Third Quarter 2013 Financial Results
3. ULURU Inc. Announces Conference Call To Discuss Financial Results For The Third Quarter Ended September 30, 2013
4. ULURU Inc. Completes Redemption Of Preferred Stock
5. ULURU Inc. Reports Second Quarter 2013 Financial Results
6. ULURU Inc. Announces Conference Call To Discuss Financial Results For The Second Quarter Ended June 30, 2013
7. ULURU Inc. Reports First Quarter 2013 Financial Results
8. ULURU Inc. Announces Conference Call To Discuss Financial Results For The First Quarter Ended March 31, 2013
9. ULURU Inc. Reports Financial Results For Fourth Quarter And Year Ending December 31, 2012
10. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Fourth Quarter and Year Ended December 31, 2012 and to Provide a Business Update
11. ULURU Inc. Business Update And Outlook
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... Cryoablation, Electrical, Endometrial Hydrothermal, Laser/Light, Microwave, Radiofrequency, Ultrasound, Cardiovascular, Gynaecology, ... expected to grow at a CAGR of 9.4% from 2017-2022 and ... at a CAGR of 9.5% from 2017 to 2027. The market ... ... benefit you Read on to discover how you can exploit ...
(Date:2/17/2017)... 2017 Arvinas LLC, a private biotechnology company ... degradation, today announced the presentation of new preclinical data ... poster session at the American Society of Clinical Oncology ... Orlando, FL. "The new ... the potential of PROTACs to drive durable and robust ...
(Date:2/17/2017)... and Markets has announced the addition of the "Pharmaceutical Contract Manufacturing ... ... the US, Canada , Japan , ... of World. Annual estimates and forecasts are provided for the period 2015 ... Market data and analytics are derived from primary and secondary research. ...
Breaking Medicine Technology:
(Date:2/17/2017)... FL (PRWEB) , ... February 17, 2017 , ... ... software tools that allow for the electronic prescribing of controlled and non-controlled substances ... , Ninety percent of pharmacies in the United States now accept electronic prescriptions, ...
(Date:2/17/2017)... ... February 17, 2017 , ... Empowering each person's mental functions, ... each and every seminar, session and class she offers. At the International ... which help energize creativity, focus mental functions, enhance athletic focus and skill sets, ...
(Date:2/17/2017)... , ... February 17, 2017 , ... ... the HIMSS17 Conference & Exhibition in Orlando, Fla., February 19-23. Visitors to the ... the most widely used electronic patient signatures solution in healthcare . ...
(Date:2/17/2017)... ... February 17, 2017 , ... Pharmica Consulting attended ... all facets of clinical trial planning and management. Pharmica discussed the importance of ... In addition, attendees stopping by Pharmica’s booth were able to demo its cloud-based ...
(Date:2/17/2017)... ... 17, 2017 , ... Like most hospitals across the nation, Onslow Memorial Hospital ... the Hospital Readmission Reduction Program (HRRP), the return of a patient to the hospital ... the nation. While many providers are struggling to leverage limited resources and technology, Onslow ...
Breaking Medicine News(10 mins):